A recent study discussed that the outcome of SARS-CoV-2 infection differs among individuals, potentially because of varying levels of proteases responsible for degrading the virus [21], and NSPs degrade the S protein of SARS-CoV-2, consequently reducing viral infection [13]. The gene discussed is PROS1; the disease is viral infectious disease.